References
- Kjos S L, Buchanan T A. Gestational diabetes mellitus. New Engl J Med 1999; 341: 1749–1756
- Crowther C A, Hiller J E, Moss J R, McPhee A J, Jeffries W S, Robinson J S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Engl J Med 2005; 352: 2477–2486
- Sermer M, Naylor D, Gare D J, Kenshole A B, Richie J WK, Farine D, Cohen H R, McArthur K, Holzapfel S, Biringer A, et al. Impact of increasing carbohydrate tolerance on maternal–fetal outcomes in 3637 women without gestational diabetes: The Toronto tri-hospital gestational diabetes project. Am J Obstet Gynecol 1995; 173: 146–156
- Jensen D M, Ovesen P, Beck-Nielsen H, Molsted-Pedersen L, Sorensen B, Vinter C, Damm P. Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women. Diabetes Care 2005; 28: 2118–2122
- Catalano P M, Drago N M, Amini S B. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol 1995; 172: 1464–1470
- Lopez-Bermejo A, Fernandez-Real J M, Garrido E, Rovira R, Brichs R, Genaro P, Bach C, Cabrero D, Kihara S, Funahashi T, et al. Maternal soluble tumor necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birth weight. Clin Endocrinol 2004; 61: 544–552
- Tjoa M L, van Vugt J M, Go A T, Blankenstein M A, Oudejans C B, van Wijk I J. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59: 29–37
- Retnakaran R, Hanley A J, Raif N, Connelly P W, Sermer M, Zinman B. C-reactive protein and gestational diabetes: The central role of maternal obesity. J Clin Endocrinol Metab 2003; 88: 3507–3512
- Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004; 27: 274–275
- Retnakaran R, Hanley A J, Raif N, Connelly P W, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: A potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799–800
- Retnakaran R, Hanley A J, Raif N, Hirning C R, Connelly P W, Sermer M, Kahn S E, Zinman B. Adiponectin and beta cell dysfunction in gestational diabetes: Pathophysiological implications. Diabetologia 2005; 48: 993–1001
- Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599
- Rifai N, Tracy R P, Ridker P M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136–2141
- Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462–1470
- Kirwan J P, Huston-Presley L, Kalhan S C, Catalano P M. Clinically useful estimates of insulin sensitivity during pregnancy: Validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24: 1602–1607
- Kramer M S, Platt R W, Wen S W, Joseph K S, Allen A, Abrahamowicz M, Blondel B, Bréart G, et al. (Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System). A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: e35–41
- Ricart W, Lopez J, Mozas J, Perichot A, Sancho M A, Gonzalez M, Balsells M, Luna R, Cortázar A, Navarro P, , (Spanish Group for the Study of the Impact of Carpenter and Coustan GDM Thresholds), et al. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycemia. Diabetologia 2005; 48: 1736–1742
- Moses R G, Calvert D. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Is there a continuum of risk?. Diabetes Care 1995; 18: 1527–1533
- Chan T F, Yuan S S, Chen H S, Guu C F, Yeh Y T, Chung Y F, Jong S B, Su J H, et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birth weights. Acta Obstet Gynecol Scand 2004; 83: 165–169
- Tsai P J, Yu C H, Hsu S P, Yee Y H, Huang I T, Ho S C, Chu C H, et al. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: Negative association with gestational diabetes mellitus. Nutrition 2005; 21: 1095–1099
- Verhaeghe J, van Bree R, Van Herck E. Maternal body size and birth weight: Can insulin or adipokines do better?. Metabolism 2006; 55: 339–344
- Ong G K, Hamilton J K, Sermer M, Connelly P W, Maguire G, Zinman B, Hanley A J, Retnakaran R. Maternal serum adiponectin and infant birth weight: The role of adiponectin isoform distribution. Clin Endocrinol 2007; 67: 108–114
- McCarron P, Davey Smith G, Hattersley A T. Type 2 diabetes in grandparents and birth weight in offspring and grandchildren in the ALSPAC study. J Epidemiol Community Health 2004; 58: 517–522
- Martinez-Cordero C, Amador-Licona N, Guizar-Mendoza J M, Hernandez-Mendez J, Ruelas-Orozco G. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small for gestational age infants. Arch Med Res 2006; 37: 490–494